| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Preprečevanje in zdravljenje zapletov kronične limfocitne levkemije : (prikaz primera)
Authors:ID Glaser, Marjana (Author)
ID Glaser, Andrej (Author)
Files:.pdf Zdravniski_vestnik_2011_Glaser,_Glaser_Preprecevanje_in_zdravljenje_zapletov_kronicne_limfocitne_levkemije_(prikaz_primera).pdf (539,10 KB)
MD5: 85BE01D92F12986AFE73037278B20CCE
 
URL http://vestnik.szd.si/index.php/ZdravVest/article/view/829
 
Language:Slovenian
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Abstract:Izhodišča: Najpogostejši zapleti kronične limfocitne levkemije (KLL) so: okužbe, avtoimunski pojavi in pojav sekundarnega raka, kar vse je posledica spremenjenega delovanja imunskega sistema. Vzroki za oslabljeno humoralno in celično imunost so kvalitativne in kvantitativne napake limfocitov B in T, nevtrofilcev, naravnih celic ubijalk in monocitno/makrofagnega sistema. Prikaz primera: Prikazan je bolnik s KLL, pri katerem je bila v času okužbe dihal ugotovljena avtoimunska hemolitična anemija (AIHA). Bolnik je bil uspešno zdravljen s steroidi, intravenskimi imunoglobulini (IVIG), antibiotikiin transfuzijami eritrocitov. Nekaj let kasneje ob ponovni okužbiin AIHA je bil zdravljen na enak način. Ker je imel stranske učinke po zdravljenju s steroidi, je bil uspešno zdravljen z rituximabom. Zaradi hipogamaglobulinemije in številnih prehladov brez ponovitve AIHA je prejemal profilaktično IVIG. Bolnik je že nekaj let v remisiji, brez anemije, pred leti je bil operiran zaradi karcinoma ledvice, letos pa zaradi karcinoma kože. Zaključki: Med avtoimunskimi pojavi sta najpogostejši AIHA in imunska trombocitopenija (IT). Zdravljenje AIHA in IT temelji na podpornem zdravljenju, zdravljenju s steroidi, IVIG, splenektomiji, v zadnjih letih pa na monoklonskih protitelesih. Pri večini bolnikov opažamo hipogamaglobulinemijo s posledičnimi pogostimi okužbami. Pri teh bolnikih je profilaktično dajanje IVIG priporočljivo, vendar ne zmanjša smrtnosti. Cepljenje je koristno v začetnih stopnjah bolezni.
Keywords:kronična limfocitna levkemija, hipogamaglobulinemija, avtoimunska hemolitična anemija, imunska trombocitopenija, okužbe, cepljenje
Publication version:Version of Record
Year of publishing:2011
Number of pages:str. 957-962
Numbering:Letn. 80, št. 12
PID:20.500.12556/DKUM-65281 New window
ISSN:1318-0347
UDC:616.1
ISSN on article:1318-0347
COBISS.SI-ID:4158527 New window
NUK URN:URN:SI:UM:DK:IP8UA1JO
Publication date in DKUM:28.03.2017
Views:3241
Downloads:199
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Zdravniški vestnik. glasilo Slovenskega zdravniškega društva
Publisher:Slovensko zdravniško društvo
ISSN:1318-0347
COBISS.SI-ID:32893696 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Licensing start date:28.03.2017

Secondary language

Language:English
Title:Prevention and treatment of complications of chronic lymphocytic leukemia : (Case presentation)
Abstract:Background: Infections, autoimmune complications and secondary cancers are the most frequent complications of chronic lymphocytic leukemia (CLL) . All are the result of modified immune system. The causes of attenuated humoral and cellular immunity lay in the qualitative and quantitative defects of B and T lymphocytes, as well as of neutrophils and monocytes/ macrophages. Case report: A patient with CLL is shown, in whom autoimmune hemolytic anemia (AIHA) was found at the time of respiratory infection . The patient was succesfully treated with steroids, intravenous immunoglobulins (IVIG), antibiotics and blood transfusions. Some years later, having respiratory infection and AIHA again, he was treated in the same way, but had side effects after steroid therapy. So he was succesfully treated with rituximab. Because of hypogammaglobulinaemia and repeated colds without worsening of AIHA he was receiving prophylactic IVIG monthly. He has been in remission for a couple of years now without AIHA, but in the last time he underwent surgery for renal and skin carcinoma. Conclusion: Among autoimmune complications, AIHA and immune thrombocytopenia (IT) are most frequent. The treatment is based on supportive care, corticosteroids, IVIG, splenectomy, and in last years also on monoclonal antibodies. Hypogammaglobulinemia is present in virtually all patients with consequent frequent and serious infections. In this group of patients prophylactic use of IVIG is recommended, but it does not reduce mortality. Vaccination is useful if used in earlier stages of CLL.
Keywords:chronic lymphocytic leukemia, hypogam maglobulinemia, aut oimmune hemolytic anemia, immune thrombocytopenia, infections, vaccination


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica